Medscape: Mild Liver Enzyme Increases Seen in COVID-19 Patients in China

UC digestive diseases expert discusses COVID-19's impact on the liver

Close to 30% of COVID-19 patients presented with mildly elevated liver enzymes in a retrospective study in China. Enzyme levels did not rise significantly during hospitalization and no patients experienced liver failure, however. Kenneth Sherman, MD, PhD, Director of the UC Division of Digestive Diseases and UC Health physician, spoke with journalist Marilynn Larkin about possible liver damage associated with SARS-CoV-2 and how pre-existing liver disease could make individuals more susceptible to infection leading to COVID-19.

Read the entire interview online.

Learn more about Sherman's COVID-19 research.

Featured image at top: Kenneth Sherman, MD, PhD, shown in the UC College of Medicine. Photo/Colleen Kelley/UC Creative + Brand.

Next Lives Here

The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.

Related Stories

2

A 'night on the Serengeti' — in Cincinnati

Event: April 12, 2025 6:30 PM

University of Cincinnati and Village Life Outreach Project celebrate two decades of service to communities in rural Tanzania. The milestone will be honored on April 12 with a vibrant fundraiser titled “Village Life: Night on the Serengeti,” hosted at Cincinnati’s contemporary 21c Museum Hotel. The evening promises Tanzanian cuisine, art, live performance and, most importantly, a renewed call to sustain a mission that has transformed lives across continents.

Debug Query for this